Search Page

1

Cite

Share

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.

Nauck MA, McGuire DK, Pieper KS, Lokhnygina Y, Strandberg TE, Riefflin A, Delibasi T, Peterson ED, White HD, Scott R, Holman RR. Nauck MA, et al. Cardiovasc Diabetol. 2019 Sep 3;18(1):116. doi: 10.1186/s12933-019-0921-2. Cardiovasc Diabetol. 2019. PMID: 31481069 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies.

Alkhezi OS, Alsuhaibani HA, Alhadyab AA, Alfaifi ME, Alomrani B, Aldossary A, Alfayez OM. Alkhezi OS, et al. Prim Care Diabetes. 2021 Oct;15(5):761-771. doi: 10.1016/j.pcd.2021.04.005. Epub 2021 Apr 26. Prim Care Diabetes. 2021. PMID: 33926837 Review.

Cite

Share

3

Cite

Share

Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study.

Zerovnik S, Kos M, Locatelli I. Zerovnik S, et al. BMJ Open. 2021 Sep 13;11(9):e051549. doi: 10.1136/bmjopen-2021-051549. BMJ Open. 2021. PMID: 34518273 Free PMC article.

Cite

Share

4

Cite

Share

Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials.

Yang DY, He X, Liang HW, Zhang SZ, Zhong XB, Luo CF, Du ZM, He JG, Zhuang XD, Liao XX. Yang DY, et al. Cardiovasc Diabetol. 2019 Apr 8;18(1):47. doi: 10.1186/s12933-019-0853-x. Cardiovasc Diabetol. 2019. PMID: 30961600 Free PMC article.

Cite

Share

5

Cite

Share

Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial.

Zhang J, Xian TZ, Wu MX, Li C, Pan Q, Guo LX. Zhang J, et al. Cardiovasc Diabetol. 2020 Apr 25;19(1):48. doi: 10.1186/s12933-020-01014-7. Cardiovasc Diabetol. 2020. PMID: 32334592 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy.

Shiraki A, Oyama JI, Nishikido T, Node K. Shiraki A, et al. Cardiovasc Diabetol. 2019 Nov 28;18(1):164. doi: 10.1186/s12933-019-0966-2. Cardiovasc Diabetol. 2019. PMID: 31779634 Free PMC article.

Cite

Share

7

Cite

Share

Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.

Thein D, Christiansen MN, Mogensen UM, Bundgaard JS, Rørth R, Madelaire C, Fosbøl EL, Schou M, Torp-Pedersen C, Gislason G, Køber L, Kristensen SL. Thein D, et al. Cardiovasc Diabetol. 2020 Jul 6;19(1):107. doi: 10.1186/s12933-020-01078-5. Cardiovasc Diabetol. 2020. PMID: 32631337 Free PMC article.

Cite

Share

8

Cite

Share

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis.

Fei Y, Tsoi MF, Cheung BMY. Fei Y, et al. Cardiovasc Diabetol. 2019 Aug 28;18(1):112. doi: 10.1186/s12933-019-0916-z. Cardiovasc Diabetol. 2019. PMID: 31462224 Free PMC article.

Cite

Share

9

Cite

Share

A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.

Webb DR, Htike ZZ, Swarbrick DJ, Brady EM, Gray LJ, Biglands J, Gulsin GS, Henson J, Khunti K, McCann GP, Waller HL, Webb MA, Sargeant JA, Yates T, Zaccardi F, Davies MJ. Webb DR, et al. Diabetes Obes Metab. 2020 Jul;22(7):1187-1196. doi: 10.1111/dom.14023. Epub 2020 Apr 1. Diabetes Obes Metab. 2020. PMID: 32157772 Free article. Clinical Trial.

Cite

Share

10

Cite

Share

Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE.

Liang B, Gu N. Liang B, et al. Cardiovasc Diabetol. 2020 Jul 6;19(1):106. doi: 10.1186/s12933-020-01088-3. Cardiovasc Diabetol. 2020. PMID: 32631360 Free PMC article.

Cite

Share